FIM
OSIR

Freedom Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Freedom Investment Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-84,110
Closed -$740K – 1237
2018
Q1 		$740K Buy
84,110
+1,599
+2% +$14.1K 0.04% 473
2017
Q4 		$495K Buy
82,511
+2,131
+3% +$12.8K 0.03% 635
2017
Q3 		$370K Sell
80,380
-4,138
-5% -$19K 0.02% 739
2017
Q2 		$541K Buy
84,518
+383
+0.5% +$2.45K 0.03% 537
2017
Q1 		$404K Sell
84,135
-10,015
-11% -$54.4K 0.02% 629
2016
Q4 		$462K Sell
94,150
-25,692
-21% -$132K 0.03% 516
2016
Q3 		$594K Sell
119,842
-3,775
-3% -$19.3K 0.04% 403
2016
Q2 		$629K Buy
123,617
+4,944
+4% +$26.6K 0.04% 346
2016
Q1 		$678K Buy
118,673
+389
+0.3% +$2.72K 0.05% 308
2015
Q4 		$1.23M Buy
118,284
+95,898
+428% +$1.3M 0.09% 173
2015
Q3 		$115K Sell
22,386
-54,083
-71% -$1.04M 0.01% 650
2015
Q2 		$1.49M Buy
76,469
+22,185
+41% +$393K 0.15% 94
2015
Q1 		$954K Buy
54,284
+26,755
+97% +$449K 0.11% 149
2014
Q4 		$440K Buy
27,529
+16,938
+160% +$227K 0.06% 315
2014
Q3 		$133K Buy
+10,591
New +$151K 0.02% 469

Other funds holding OSIR

Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Freedom Investment Management's OSIR Position: Q2 2018 in Review

Freedom Investment Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2018, closing a stake of 84,110 shares — an estimated $740K sold.

Freedom Investment Management first reported a position in OSIR in Q3 2014 and held it in 15 quarters. The position peaked at $1.49M in Q2 2015. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2018.

  • Freedom Investment Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Freedom Investment Management sold 84,110 Osiris Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $740K.
  • Freedom Investment Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2014 and held it in 15 quarters.
  • Freedom Investment Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.49M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Freedom Investment Management's 13F filing for Q2 2018, filed 27 Jul 2018.